Healthcare and life sciences in Israel

Goldfarb Seligman & Co.

Top-notch life sciences firm’, Goldfarb Seligman & Co. houses a multi-disciplinary practice, which handles a mix of transactional, regulatory and contentious matters for an impressive roster of major Israeli and global names. Chairman Eli Zohar is a key contact on the litigation side and has served as the Israeli Medical Association’s lead outside counsel for 19 years. Sharon Gazit, who heads the corporate and technology department, is a respected transactional specialist and has recently led work for EarlySense, Takeda Pharmaceutical and Elekta. Additional contacts include Ashok Chandrasekhar, who heads the international corporate and securities team, and corporate and capital markets lead Dubi Zoltak.

Practice head(s):

Eli Zohar; Sharon Gazit; Ashok Chandrasekhar; Dubi Zoltak


Top-notch life sciences firm in Israel, strong in medtech and biotech and with an international reach.’

Sharon Gazit is a very reliable lawyer, acquainted with international deals and takes a business approach.’

Key clients

BrainsGate Ltd.

EarlySense Ltd.

Takeda Pharmaceutical Company Limited

ReWalk Robotics Ltd.

Lilach- Live and Die with Dignity

The Israeli Medical Association

Elekta AB

Carestream Health, Inc.

Aquafit Intimate Ltd.

Bar-Ilan Research & Development Company Ltd. (BIRAD)

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (Yissum)

Wize Pharma Ltd.

Breath of Life International Ltd. (BOL Group).

Cannbit Ltd.


QuickRing Medical Technologies Ltd.

Cycla Orthopedics Ltd.

Anchiano Therapeutics

Itamar Medical Ltd.

Medtronic plc

Menorah Insurance Company Ltd.

Medhub Ltd.

Hy-Breed Genetix, Ltd.

Work highlights

  • Advised EarlySense on all corporate, intellectual property, employment law and real estate matters, including advising on agreements for the distribution of its home product, Early Sense Live.
  • Acted for Takeda Pharmaceutical on all Israeli aspects of its $62bn acquisition of Shire.
  • Advised Itamar Medical on its listing and IPO on the Nasdaq.

Herzog Fox & Neeman

Herzog Fox & Neeman’s full-service healthcare and life sciences offering is particularly valued for its ‘vast experience of the regulations of the life sciences market’. Aside from its dominant regulatory practice, the team also excels in IP and technology licensing, corporate and finance transactions and litigation. Department co-head Zohar Yahalom provides ‘innovative strategic solutions’ and is distinguished by his dedicated sector focus; he specialises in advising a broad array of pharmaceutical, biotech and medical device companies on commercial and compliance matters. Neta Dorfman Raviv, who heads the healthcare and insurance teams, and hi-tech specialist Dan Sharot are also noted.

Practice head(s):

Zohar Yahalom; Neta Dorfman Raviv


The HFN team has a wide range of experience in all aspects of this complex field and the capability to skilfully manage and creatively close a variety of healthcare deals.’

The team possesses unique knowledge and vast experience of the regulations of the life sciences market.’

They are responsive and hard-working with a detail-oriented approach that provides assurance to in-house counsel that every possible item of the transaction is under control.’

Zohar Yahalom is practical and provides fast and thorough replies, including innovative strategic solutions to issues at hand.’

Key clients

Assuta Ashdod

Assuta Medical Centers

Maccabi Health Services

Magen David Adom



Merck Serono

Leadiant Biosciences

GE HealthCare


Novo Nordisk

Philips Healthcare

Isotopia Molecular Imaging

Super Pharm

Work highlights

  • Represented Isotopia Molecular Imaging in administrative litigation against the Ministry of Health.
  • Advised Assuta Medical Center on a string of commercial matters, including on an IP and data licence agreement with AIVF.
  • Acted for Medisafe on several licensing and SaaS transactions with global pharmaceutical companies.

Horn & Co

Life sciences and hi-tech boutique Horn & Co has a premier reputation for its broad industry expertise, with strong skill sets in M&A, corporate finance, IP, research-related issues and commercial partnerships. The firm’s strategic focus on representing biotechnology and medical device companies and investors translates into an impressive client list spanning Israeli start-ups through to major multinationals, including Protalix BioTherapeutics, Lutris Pharma and Vascular Biogenics. High-profile figure Yuval Horn is widely acknowledged as a sector specialist and leads a team that also includes New York and Israel-qualified Keren Kanir.

Practice head(s):

Yuval Horn


Yuval Horn is a key name for technology and life sciences M&A deals.’

Key clients

Pontifax VC

Protalix Biotherapeutics Inc.

Vascular Biogenics Ltd.

Biolight Life Sciences Ltd.

Aposense Ltd.

Zebra Medical Vision

Biosight Ltd.

Lutris Pharma Ltd.

Work highlights

  • Advised Anima Biotech on a $1bn license agreement with Eli Lilly.
  • Acted for the shareholders of Famewave on its acquisition by Kitov Pharma.
  • Advised Zebra Medical Vision on a $30m financing round.

Lipa Meir & Co

Lipa Meir & Co’s well-rounded practice combines top-level firepower in regulatory, transactional and contentious issues, with sources valuing its collaborative approach, which ‘adds value when addressing complex issues’. The firm’s profile in the healthcare area is demonstrated by its close relationship with Clalit Health Services, which is Israel's largest health maintenance organisation (HMO) and the second-largest HMO in the world. Alongside healthcare providers, the group also counts medical device manufacturers and pharmaceutical companies among its clients. Key names include international practice head Gary Copelovitz, who has an emphasis on corporate and commercial transactions, Roy Aiz and Yariv Shalom.

Practice head(s):

Gary Copelovitz


The strengths of the team are its diverse industry expertise, as well as its lawyers’ ability to delve into each issue.’

Lawyers collaborate on consultations, which adds value when addressing complex issues.’

The partners with whom I work are very committed and professional.’

Key clients

Mileutis Ltd.

Clalit Health Services

Mor Institute for Medical Data Ltd.

Mor Research Applications Ltd.

Mor-Mar Ltd.

Shila Medical Services Ltd.

NARA Medical Center

Medtechnica – Orthophone Ltd.

MediRisk Solutions Ltd.

Natural Childbirth Center

Tel Bar Industries For Health Institutions Ltd.

Clalit – Biomedical Engineering Ltd.

Clal Insurance Company Ltd. (“Clal”)

Nevo Robotica

Dikla Insurance Company Ltd.

TransEnterix Inc

Shareholders in Unipharm Ltd.

Work highlights

  • Advised Clalit Health Services on its joint venture with BC Platforms to establish a ‘bio bank’, which combines BC Platforms’ analytics software with genomic and clinical data collected and provided by Clalit.
  • Advised Mor-Mar on day-to-day matters, including regulation, joint ventures and licensing agreements.
  • Acted for TransEnterix on its acquisition of MST Medical Surgery Technologies.

M. Firon & Co Advocates and Notaries

M. Firon & Co Advocates and Notaries’ first-class client list strikes a balance between major Israeli and global pharmaceutical companies, including Gilead, Sanofi and the umbrella organisation for the Israeli pharmaceutical industry, Pharma Israel. On the healthcare side, it acts for Clalit Health Services and the Medical Centre for Treating Diabetes. Arguably best known for its ‘special regulatory understanding’, the team also advises on commercial agreements, M&A and contentious matters. Baruch Shugol is ‘probably the most prominent lawyer in the field’ and his practice spans the full life cycle of life sciences work, from research and development and commercial agreements, through to litigation. M&A head Jacob Enoch and corporate and commercial partner Sivan Narkiss Kremer are also active in this space.

Practice head(s):

Baruch Shugol; Sivan Narkiss Kremer


M. Firon is considered the best firm in the country in this area – representing large pharma companies, medical centers, HMOs, etc. They have a special regulatory understanding and ample experience in handling the regulator.

They work closely on our cases; any team members involved, including the senior partners, are available and know the details. They assist in decision-making.

Their experience in the matters we are dealing with, increase their contribution to our cases and makes service delivery faster and more efficient.’

Baruch Shugol is probably the most prominent lawyer in the field. In decades of practice, he really has seen it all.’

Jacob Enoch – as always – our go-to-guy. A magician.’

Key clients


Clalit Health Services

The centre for the blind in Israel

Pharma Israel



Geffen Medical

S.L.H. Medical Services Ltd.

Guangzhou Sino-Israel Bio-industry Venture Capital Investment Fund


Tel Aviv Sourasky Medical Center

Work highlights

  • Advised Pharma Israel, an organisation of R&D-based drug companies, on regulatory matters.
  • Acted for Paltop Advanced Dental Solutions on its $50m merger with Keystone Dental.
  • Advised Gilead on day-to-day operational matters, including corporate governance and litigation.

S. Horowitz & Co

A force in the life sciences field, S. Horowitz & Co advises major industry participants on a diverse mix of commercial, regulatory and contentious matters. In particular, the firm leverages its strong IP offering to provide expertise in licensing and distribution agreements, as well as IP litigation. The ‘professional, attentive and accurate’ team also leans on other departments in the firm to provide supplementary expertise in product liability, class actions and technology transfers. The multi-disciplinary practice is led jointly by Dovev Apel, who specialises in advising life sciences companies on IP issues, and IP chair Tal Band. Litigator Asaf Rentsler is also recommended.

Practice head(s):

Tal Band; Dovev Apel


The team has a lot of knowledge in a very unique field.’

The team is professional, attentive and accurate. Perfect case management, efficiency and availability.’

Dovev Apel is smart, professional, attentive and accurate.


Key clients

Teva Pharmaceutical Industries Ltd.

The Chemical, Pharmaceutical and Environmental Society of the Manufacturer’s Association of Israel

Maccabi Healthcare Services

Procter & Gamble Israel Ltd

Dexcel Ltd. and Dexcel Pharma Technologies Ltd.

Shire International GmbH

Humacyte Inc.

Novocure Inc.

Hadassah Medical Organization

Allergan Inc.

Perrigo UK Finco Limited Partnership and Perrigo Israel Pharmaceuticals Ltd.


Smith & Nephew

SelfCare Pro

Indena S.p.A.

Forever Living Products (Israel) Limited

Perfetti Van Melle

Taro Pharmaceutical Industries Ltd.

Genmab A/S

Medial Group

Santhera Pharmaceuticals

Yeda Research and Development Limited


I.S.R – The Institute for Skin Research

Zimmer Biomet

Takeda Pharmaceutical Company

Work highlights

  • Advised Teva on day-to-day matters, including product issues, clinical trials, brand management and IP litigation.
  • Represented Maccabi Healthcare Services in more than a dozen class action lawsuits, among other matters.
  • Advised Dexcel on various contentious and regulatory matters in the field of pharmaceuticals and medical devices.

Tadmor Levy & Co

According to sources, Tadmor Levy & Co differentiates itself through its ‘unique multi-disciplinary professionalism’. Certainly, the dedicated practice covers a comprehensive range of healthcare and life sciences matters, with clients hailing its capabilities in regulation, clinical trials, commercial transactions and litigation. Perhaps best known for its close relationship with Israel’s largest chain of private hospitals, Assuta Medical Centers, the team also acts for an extensive roster of Israeli and multinational pharmaceutical and medical device manufacturers. Department head Efrat Shapira-Orren stands out for her ‘in-depth and wide-ranging oversight of this field’. Key names at associate level include the ‘very talentedAvital Bruker-Yamin, as well as Avi Farchi, who is noted for his expertise in clinical trials.

Practice head(s):

Efrat Shapira-Orren


The healthcare field is very complicated and requires dealing with comprehensive regulation and many difficult issues. The service we receive from Tadmor Levy is of a very high level, they know how to deal with all the issues and give us excellent consultation. They are better than any other office I have worked with during dozens of years in this field.

The healthcare team at Tadmor Levy & Co is very professional and very familiar with all aspects of the healthcare and life sciences field.’

They are very precise, identifying both legal and commercial points that require special attention, and provide creative solutions.’

They are dedicated, responsive and committed to their role and to the client. They have become an internal part of our team, in a way that no other legal advisors have managed to do here before.’

The team at Tadmor exemplifies great knowledge of all aspects of healthcare law.

Tadmor Levy brings unique multi-disciplinary professionalism and one of a kind talent and commitment. It is rare to review a firm that provides such a broad spectrum of services with excellence. It enables us to avoid looking for specific strength in other firms because the table is surrounded by highly valuable professionals covering regulation, business, workers relations and others.

The diversity of the firm’s department allows for the provisions of high-level professional advice on all aspects of the activity of healthcare providers; including regulation and compliance, commercial transactions, clinical trials, M&A, competition laws, litigation etc.’

The fact that the firm has a dedicated healthcare practice, which centralises the legal advice, with the necessary assistance of other departments, gives them in-depth knowledge of the field and brings their legal services to a higher level than that of other firms.’

Alongside their professionalism, they are also very service-oriented, which makes them very pleasant to work with.’

The firm has an experience and knowledge in the health industry and, to my mind, is a very unique firm in Israel.

Efrat Shapira-Orren is an expert lawyer, with unique experience in the health industry. I would also like to emphasise her contribution to business decision-making.’

Efrat Shapira-Orren is an extremely talented lawyer who provides unique value through combining legal with commercial capabilities.

Efrat is one of the best professionals in this field by integrating the “big strategic picture” with the specific day-to-day business.’

Efrat Shapira-Orren is very professional, creative and committed. She identifies the fundamental issues and risks, and guides us on all legal matters, as well as on business analysis and commercial aspects.’

Efrat Shapira-Orren possesses a very unique knowledge and understanding of the very complex nature, structure and challenges of the Israeli healthcare market. No other private lawyer has such an in-depth and wide-range oversight of this field.

Efrat’s broad legal knowledge and deep background in administrative law and project financing bring her legal, as well as commercial, capabilities to a higher level than that of other lawyers. She is extremely thorough, professional and diligent in her work, making sure that every aspect is properly covered.’

Besides her legal capabilities, Efrat is very involved in the business of the company. She brings substantive value in structuring transactions and creating new fields of activities. She is also very creative in finding legal and commercial solutions and making the deal go through.’

Efrat Shapira-Orren is excellent — very professional, experienced and has a comprehensive knowledge in the field of healthcare. She gives high-level service, and a thorough consultation.’

Efrat is definitely one of the leading lawyers in this field.’

Efrat Shapira-Orren’s high level of professionalism, meticulousness and friendly support was critical for dealing with numerous obstacles, dealing with regulators and leading our way through an extremely convoluted process.

Avital Bruker-Yamin is also very talented, committed and professional. She works hard, pays attention to details and provides a very good service on a variety of matters related to the healthcare field.’

Avital Bruker-Yamin is a hard worker, goes into all details, and is always available to assist. She is very motivated, and invests time and effort in order to be very deeply involved in every matter she handles.’

Avi Farchi is very familiar with the field of clinical trials, and he advises on all stages of the process — from initial review and approval of proposed trials, to forming and negotiating the clinical trial agreements.’

Avi Farchi is very pleasant, service-oriented and professional.

Key clients

Assuta Medical Centers Ltd. and all subsidiaries  thereof

Assuta Ashdod Ltd.

Incentive Incubator Ltd.

SAREL Supplies & Services for Medicine Ltd.

Corsens Medical Ltd

Sinusafe Medical Ltd.

ArTack Medical (2013) Ltd.

Allergan Plc

Gilot Capital Partners

Anthem Insurance Companies, Inc.

Baxter Healthcare Distribution Ltd.

Takeda Pharmaceutical Company Ltd. / Shire Plc

Work highlights

  • Advised Assuta Medical Centers on all its legal issues, including regulatory matters and litigation.
  • Represented Allergan in a motion to approve a derivative action against Teva and its office holders, with respect to Teva’s $40.5bn acquisition of Allergan’s generic division.
  • Advised Sarel Supplies & Services for Medicine on various regulatory issues.

Tulchinsky Stern Marciano Cohen Levitski & Co.

Tulchinsky Stern Marciano Cohen Levitski & Co.’s practice is complemented by the wider firm’s robust hi-tech offering, and it has an impressive record in representing start-ups in the med-tech and biotech fields. The group also acts for established Israeli and global industry leaders, including Teva and Orbotech. Cross-border work is another strength, particularly in the research area where it advises life sciences clients on license, cooperation and clinical trial agreements with academic institutions in Israel, the US and Europe. Corporate and commercial partner Uriel Barak jointly heads the team alongside Alon Tabak-Aviram, who specialises in international business and technology transactions.

Practice head(s):

Uri Barak; Alon Tabak-Aviram

Work highlights

  • Advised Visionix on its initiatives to set up research and manufacturing facilities in China through a joint venture with a Chinese consortium.
  • Advised RedHill BioPharma on its exclusive license to market a drug in the US to gastroenterologists.
  • Advised the National Institute for Biotechnology in the Negev on licensing, joint ventures and collaboration activities in Israel and abroad.

Yigal Arnon & Co

Best known for its transactional weight in the life sciences sphere, Yigal Arnon & Co acts for a diverse mix of start-ups through to global corporations and investors. The group’s recent impressive run of M&A deals included advising on sizeable acquisitions for global industry leaders, including Stryker Corporation and Medtronic, as well as Israeli companies such as Enlivex Therapeutics. It also handled a wide range of regulatory, IP and commercial work. Daniel Green heads the transactional IP department and focuses on licensing, corporate partnering and intellectual property. Additional contacts include corporate finance heavyweight Barry Levenfeld and Yoheved Novogroder-Shoshan, who has an emphasis on technology, IP, joint ventures and privacy issues.

Practice head(s):

Daniel Green; Yoheved Novogroder-Shoshan; Barry Levenfeld

Key clients

Medtronic Inc.

Teva Pharmaceutical Industries Ltd.

FutuRx Ltd.

MEDX XELERATOR, Limited partnership

Algatechnologies Ltd

Stryker Corporation.

Enlivex Therapeutics Ltd.

Restoration Robotics, Inc.

Hutchison China MediTech (Chi-Med)

Keystone Heart

Alma Lasers Ltd.

Pi Therapeutics

Immpact Bio Ltd.

4C Biomed

Prilenia Therapeutics

AV Medical


Square Peg Capital

SteadyMed Ltd.

Work highlights

  • Advised Stryker on its $220m acquisition of OrthoSpace, including, corporate, IP and tax issues.
  • Acted for Medtronic on its $100m acquisition of Nutrino Health.
  • Advised Teva on privacy and other matters concerning Teva’s oncological testing services, digital health and other businesses.

Amit, Pollak, Matalon & Co. Advocates and Notary

Amit, Pollak, Matalon & Co. Advocates and Notary draws on the firm’s eminent hi-tech and venture funds practice to specialise in advising funds and start-ups in the life sciences sector. Venture capital is a strong suit and it is also routinely involved in corporate transactions. Ian Rostowsky and Yoav Etzyon, who jointly head the hi-tech and venture capital departments, are the key contacts. The firm recently added a two-partner team from ConsulTech, which included new digital technology and regulations practice head Hilla Shribman.

Practice head(s):

Ian Rostowsky; Yoav Etzyon


The team has extensive experience in assisting technology companies and in-depth recognition of needs across a variety of activities.

Provides quick responses to rising needs, including at unconventional hours, in order to meet times that are sometimes aggressive.

Ian Rostowsky accompanies the company very professionally with the intention of providing quality and fast services. He always finds a way to provide the required service in a pleasant manner, even when busy.

Key clients


Orpheus Medical

KeepMed Ltd.

aMoon Fund

aMoon Velocity Fund

MindUP Ltd.

Novartis International AG

Health& Happiness Group

Epitech Mag Ltd.

Xinteza API Ltd.

Human Mission Inc.

Hip-Hope Technologies Ltd.

DermaFence Ltd.


Chemo Group/Exeltis

Orsense Ltd.


Work highlights

  • Advised aMoon II, a fund investing in biopharma, medical devices and digital health companies, on its fund formation and fundraising.
  • Acted for RMGP Bio-Pharma Investment Fund on the formation of its venture capital fund.
  • Acted for Genae Associates on its acquisition of MedicSense from its founders.

Fischer Behar Chen Well Orion & Co

Fischer Behar Chen Well Orion & Co’s broad practice was kept busy advising on an array of licensing and commercial agreements, investment matters and litigation. The team routinely acts for Israeli and global clients, including hospitals, healthcare funds, medical device companies and pharmaceutical companies, and sources highlight its ‘strong experience with international transactions’. Raz Tepper has a strong record in hi-tech and venture-capital-related matters and jointly heads the group alongside Eran Yaniv, who is noted for his ‘outstanding knowledge’.

Practice head(s):

Raz Tepper; Eran Yaniv


The FBC team understands the pharma sector very well and the peculiarities of that sector in Israel.’

Strong experience with international transactions.

Demonstrates deep knowledge, responsiveness and care.

Eran Yaniv: outstanding knowledge. Knows to articulate complex issues and make them simple to understand. Very responsive and a nice person to work with.’

The FBC team led by Gil Orion, with Jana Rabinovich as second in command, reacted with dispatch to sudden crises, while not losing sight of the overall goals of minimising court activity.

Key clients


American Well Corporation

Hadassah Medical Organisation

Meuhedet Health Fund

OrbiMed Healthcare Fund Management

OrbiMed Israel Partners Limited Partnership

Check Cap Ltd.

A.Y. Labs Ltd.

Adicet Bio Ltd.

Allium Medical

Ammune Ltd.

Affix Ltd.

Aurum Ventures

Cannsoul Analytics

ChroniSense Ltd.


Enopace Medical Ltd.

GluSense Ltd.

Kamada Ltd.

Lifebond Ltd.

MetaboMed Ltd.

M.S.T. Medical Surgery Technologies Ltd.

Motus G.I.

NanoSpun Technologies

N.G.T New Generation Technologies Ltd.

Nano Retina Ltd.


Ocon Medical

Pangea Therapeutics Ltd.

Pythagoras Medical Ltd.

Rainbow Medical Ltd.

Real Imaging Holdings Ltd.

Hadassah Medical Ltd.

Alpha-Bio Tech Ltd.

Bristol-Meyers Squibb Company

Medica Medical Centres

VVT Medical Ltd

Work highlights

  • Represented Hadassah Medical Organisation in several matters, including in its recovery agreement with the State of Israel and Hadassah Women’s Zionist Organization of America.
  • Acted for Pangea Therapeutics on day-to-day matters, including ongoing licensing and commercial agreements, and its recent initial financing round.
  • Advised Ammune on various legal matters, including ongoing licensing and commercial agreements.

Gross, Kleinhendler, Hodak, Halevy, Greenberg, Shenhav & Co.

Gross, Kleinhendler, Hodak, Halevy, Greenberg, Shenhav & Co. fields a full-service life sciences practices that is distinguished by its ability to lean on the wider firm’s top-tier offerings in hi-tech and start-ups, investment and venture capital and corporate and M&A. The team advises an extensive roster of biotech, pharmaceutical, medical device and health companies on regulatory, commercial and corporate matters, with investment transactions and licensing agreements standing out as sweet spots. Department head Hili Cohen is noted for commercial and regulatory work. Tami Fishman Jutkowitz handles a mix of corporate finance and commercial work.

Practice head(s):

Hili Cohen

Key clients


Arkin Holdings





Cronos Group

Edwards Lifesciences Corporation

eHealth Ventures

Eximo Medical Ltd.

Igentify Ltd.

InnoBev Ltd.

InnovaHealth Partners

Inovytec Medical Solutions


Izun Pharma

Kitov Pharmaceuticals

Magenta Medical



My Ukko

NeuroSense Therapeutics

Pharmaceutical Research Associates (PRA)

Premier Research

Q-Art Ltd.

Rapid Medical Ltd

Redhill Biopharma Ltd

Sol-Gel Technologies Ltd

Spatz FGIA

Therapix Biosciences Ltd

Under Pressure

WellBeat Ltd

West Pharmaceutical Services, Inc.

Yissum Research Development

3 Millenium Group


American Well



GI View Ltd.

Intratech Medical

Maccabi Dent


Mother’s Choice








Ortho Clinical Diagnostics


Madrigal Pharmaceuticals

Industrie Biomediche Insubri


Respiration Scan

Sonivie Ltd

Vibrant Ltd

Rainbow Medical Ltd

Telesofia Medical Ltd


Work highlights

  • Advised CollPlant on a licensing, development, and commercialisation agreement with United Therapeutics in connection with 3D bioprinted human organs.
  • Advised Rapid Medical on a Series C investment transaction.
  • Advised Sol-Gel Technologies on a phase III clinical study.

Katzenell Dimant

Hi-tech and capital markets boutique Katzenell Dimant scores highly for its ‘excellent knowledge of the Israeli public and private markets’. The firm acts for companies, non-profit organisations and funds operating in the healthcare and life sciences spheres, with an emphasis on financing, market regulation and commercial agreements. Einat Katzenell is well versed in corporate, commercial and financing matters and jointly heads the group alongside Ran Dimant, who is noted as ‘an authority in the field’.

Practice head(s):

Einat Katzenell; Ran Dimant


Creative and strategic approach. Work with a sense of urgency and dedication, almost as if they are in-house counsels.’

Highly knowledgeable and meticulous. I feel confident when working with them on potential deals with third parties that are represented by the largest firms.’

It is a pleasure working with the team. First, they are professional. Second, they are fast and thorough. Third, they are always available. In my area of expertise, they know how to handle negotiations and to make sure everything meets my expectation. ’

They are more than legal consultants, they behave like each contract is their own personal contract.’

Excellent knowledge of the Israeli public and private markets.’

Provide personalised attention; partners really care about their clients and look out for them.’

The team acts as corporate advisors — looking out for the company both from a legal and business perspective.’

Ran Dimant is focused on the essence of the deal creation without compromising on protecting our interests.

Ran Dimant is very well connected to the healthcare ecosystem and is respected as an authority in the field. He leads and directs his team in the same way.

Key clients


Citrine Biotech Fund

Nextgen Biomed Ltd.

Hil Applied Materials Ltd.

Kitov Pharmaceuticals Holdings Ltd.

Dr. Moriss Laster

Dr. Moris Lester

Capital Point Ltd.


Steadymed Ltd

Hairstetics Ltd.

Holon Institute of Technology – H.I.T (R.A), and its technology transfer arm – AYYT – Technological applications and data update Ltd.

Hypnocore (Sleeprate)

Joy Ventures


BIRAD – Bar-Ilan Research & Development Company Ltd.

Earways Medical


Bubble Ltd.

TLV Medical Center Ltd.

Work highlights

  • Advised Oncohost on day-to-day matters, including financing rounds and licensing agreements.
  • Acted for Citrine Biotech Fund on a raft of issues, including its investments.  
  • Advised Nextgen Biomed on regulatory and corporate governance issues.

Liad Whatstein & Co. Law Office

IP boutique Liad Whatstein & Co. Law Office specialises in advising life sciences companies on regulatory, licensing and IP matters. The team is particularly sought after for IP disputes and regularly assists the world’s largest pharmaceutical companies with contentious matters, including Pfizer, Merck and Sanofi. Founding partner Liad Whatstein is widely recognised as a leading IP litigator. Amira Mangelus, who leads the firm’s patent prosecution group, is also a key contact.

Practice head(s):

Liad Whatstein; Amira Mangelus

Key clients









Eli Lilly


Leo Pharma





Advanced Accelerator Applications

Work highlights

  • Represented Novartis in patent litigation against a large generic pharmaceutical company concerning a patch containing rivastigmine for treating Alzheimer’s disease.
  • Acted for Sanofi in opposition and revocation proceedings relating to Amgen’s patent for a new category of biological drugs for lowering cholesterol.
  • Advised Pfizer in patent infringement proceedings against Unipharm in connection with the viagra drug.

Meitar Law Offices

Meitar Law Offices ’ life sciences practice sits as part of the technology and IP department, which gives the group an emphasis on licensing transactions, development and supply agreements and technology transfers. The full-service firm also brings together its top-tier capabilities in corporate, hi-tech and venture capital to advise pharmaceutical and healthcare clients on M&A, finance and investment matters. Key contacts include transactional specialist Haim Gueta, litigator Ron Peleg and Boaz Mizrahi, who handles IP and corporate finance.

Practice head(s):

Haim Gueta; Boaz Mizrahi; Ron Peleg

Key clients

Biokine Therapeutics Ltd.

Merck Sharp & Dohme (Israel 1996) Ltd.

Gamida Cell Ltd.

CureTech Ltd.

Clal Biotechnologies Industries

MediWound Ltd.

Glaxo SmithKline (Israel) Ltd.

Eli Lilly and Company

Nucleix Ltd.

Novartis Ltd.

Solo Gelato Ltd.

Bristol-Myers Squibb Ltd.

Pharma Two B Ltd.

DentlyTec G.P.L Ltd.

Bayer Israel Ltd.; Bayer Schering Pharma AG; Perrigo Israel Agencies Ltd.

Cantel Medical Corp

Evogene Ltd.

Pfizer Venture Investments LLC

Mapi Pharma Ltd.

Stem Cell Medicine Ltd.

C.R. Bard, Inc.

Mylan N.V.

P-Cure Ltd.

Alpha Tau Medical Ltd.

Access Industries, Inc.

Work highlights

  • Advised MediWound on license and supply agreements with Vericel Corporation to commercialise NexoBrid in North America.
  • Acted for Gamida Cell on various corporate and finance matters, including on its $94m initial and follow-on public offerings on the Nasdaq.
  • Acted for Galmed Pharmaceuticals on several matters, including on a recent research and option agreement with Yissum Research Development Company of the Hebrew University of Jerusalem.

Pearl Cohen Zedek Latzer Baratz

Pearl Cohen Zedek Latzer Baratz’s practice is significantly weighted towards IP matters, in line with its signature strength. The firm manages the patent portfolios of a string of leading industry players, including Bayer Healthcare and Sanofi. In addition, it is well versed in advising life sciences and healthcare clients on finance, securities and M&A transactions. Group co-head Mark Cohen splits his time between Israel and the US, and focuses on patent prosecution and licensing. Corporate and licensing specialist Yael Baratz jointly heads the department.

Practice head(s):

Mark Cohen; Yael Baratz 

Key clients

Opko Health Ltd.

Sanofi S.A.

Orgenesis Inc.

Bayer AG

Vertex Pharmaceuticals

SciVac Ltd.

Chiasma Inc.

KAHR Medical Ltd.

Endymed Medical Ltd.

XL Therapeutics Ltd.

FuturX Ltd.

MBcure Ltd.

Hera Med Ltd.

Vidac Pharma Ltd.

Immune Pharmaceuticals

Omnix Medical Ltd.

Merck Serono

University of Pennsylvania


Medivie Theraputic

Optimal Plus

Estar Medical

Ayala Pharmaceuticals

LDS, Lyotropic Delivery Systems

Biondvax Pharmaceuticals Ltd.

Panaxia Pharmaceutical Industries Ltd

Amoon Fund

BGN Ltd.

Pfizer Inc.

Dexcel Pharma

Aspect Imaging

CSL Behring

Maccabi Health Services

Work highlights

  • Advised Bayer, and all its subsidiaries, on filing and prosecuting patent applications in Israel.
  • Advised OPKO Health on the full scope of IP services, including patent drafting and prosecution.
  • Advised Medi-Tate on a $20m financing.

Shibolet & Co. with Raved, Magriso, Benkel & Co. 1

Shibolet & Co.’s group is routinely engaged by a wide range of industry participants, from promising start-ups, through to research centres and pharmaceutical companies. Among its strong suits, the team is particularly prominent in licensing transactions and financing deals. It also advises on product development, patent approvals, clinical studies and regulatory issues. Ofer Ben-Yehuda is 'a true partner to the client’.

Practice head(s):

Ofer Ben-Yehuda


The focus is on getting deals done, not on raising obstacles.’

The partners and associates are highly dedicated to providing the best service, protecting the interests of clients, and doing so in a professional manner.

Ofer Ben-Yehuda is a standout; Ofer is not only highly experienced and professional, but also a true partner to the client in getting deals done.

Key clients



Medasense Biometrics Ltd

OHMK (TIANJIN) medical technology ltd

EndyMed Ltd

Technion Research and Development Foundation Ltd

Dia Cardio

Emendobio Inc.

Elcam Medical

Moebius Medical

Joy Venture

Klalit TTO






Work highlights

  • Advised Apifix on a financing round worth over $3m.
  • Advised Novocure on day-to-day matters, including regulatory issues.  
  • Advised SofWave Medical on its $8.4m financing round led by XT Hi-Tech.

Zysman, Aharoni, Gayer & Co (ZAG-S&W)

Zysman, Aharoni, Gayer & Co (ZAG-S&W) houses an increasingly active life sciences practice, which handled a broad mix of corporate, finance and commercial transactions over the past year. In particular, the firm had a strong showing in the medical cannabis space. Reut Alfiah leads on the medical cannabis offering and advised Eva Fashion, one of the major private shareholders of MedReleaf, on the landmark $3.2bn merger between Aurora Cannabis and MedReleaf. Other names to note in the multi-disciplinary group includes capital markets head Oded Har-Even, international head Shy Baranov and hi-tech specialist Mor Limanovich.

Practice head(s):

Oded Har-Even; Shy Baranov; Mor Limanovich; Reut Alfiah

Work highlights

  • Advised Eva Fashion, one of the major private shareholders of MedReleaf, on the $3.2bn merger between Aurora Cannabis and MedReleaf.
  • Acted as Israeli counsel to BiomX on its $254m merger with Chardan Healthcare Acquisition Corp.
  • Advised Ossio on its $22m financing round.